Download PDF
Planta Med 2005; 71(7): 622-627
DOI: 10.1055/s-2005-871267
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

In vivo Biodistribution of Ginkgolide B, a Constituent of Ginkgo biloba, Visualized by MicroPET

Makiko Suehiro1 , 4 , Norman R. Simpson2 , Mark D. Underwood3 , John Castrillon3 , Koji Nakanishi1 , Ronald van Heertum2
  • 1Department of Chemistry, Columbia University, New York, NY, USA
  • 2Department of Radiology, Columbia University, New York, NY, USA
  • 3Department of Psychiatry, Columbia University, New York, NY, USA
  • 4Citigroup Biomedical Imaging Center, Weill Medical College of Cornell University, New York, NY, USA
Further Information

Publication History

Received: August 24, 2004

Accepted: May 17, 2005

Publication Date:
18 July 2005 (online)

    Permissions and Reprints

Abstract

The in vivo dynamic behavior of ginkgolide B (GB), a terpene lactone constituent of the Ginkgo biloba extracts, in the living animal was visualized by positron emission tomographic (PET) imaging using a GB analogue labeled with the positron emitter 18F. The in vivo imaging studies, combined with ex vivo dissection experiments, reveal that GB exists in 2 forms in the body: the original GB with its lactone rings closed and a second form with one of the rings open. The original GB in plasma is taken up rapidly by various organs including the liver, the intestine and possibly the stomach. Consequently, in plasma, the proportion of the ionized form of GB increases dramatically with time. Thereafter the ratio between the 2 forms appears to shift slowly towards equilibrium. The results suggest that more attention needs to be focused on in vivo dynamics between the 2 forms of GB.

Key words

Ginkgolide B - positron emission tomography - in vivo biodistribution of ginkgolide B - microPET - Ginkgo biloba - Ginkgoaceae

References

  • 1 Curtis-Prior P, Vere D, Fray P. Therapeutic value of Gingko biloba in reducing symptoms of decline in mental function.  J Pharm Pharmacol. 1996;  51 535-41
    PubMedGoogle Scholar
  • 2 Le Bars P L. Magnitude of effect and special approach to Ginkgo biloba extract EGb 761 in cognitive disorders.  Pharmacopsychiatry. 2003;  36 (Suppl 1) 544-9
    PubMedGoogle Scholar
  • 3 Braquet P. Ginkgolides: chemistry, biology, pharmacology and clinical perspectives. J. R. Prous Science Publishers Barcelona; 1988
    Google Scholar
  • 4 Amri H, Ogwuegbu S O, Boujrad N, Drieu K, Papadopoulos V. In vitro regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginko biloba extract EGb 761 and isolated ginkgolides.  Endocrinology. 1996;  137 5707-18
    CrossrefPubMedGoogle Scholar
  • 5 Amri H, Drieu K, Papadopoulos V. Ex vivo regulation of adrenal cortical cell steroid and protein synthesis, in response to adrenocorticotropic hormone stimulation, by Ginkgo biloba Extract Egb 761 and isolated gingkolide B.  Endocrinology. 1997;  138 5415-26
    CrossrefPubMedGoogle Scholar
  • 6 Papadopoulos V, Widmaier E P, Amri H, Zili A, Li H, Culty M. et al . In vivo studies on the role of the peripheral benzodiazepine receptor (PBR) in steroidogenesis.  Endocrine Research. 1998;  24 479-87
    PubMedGoogle Scholar
  • 7 Du Z -Y, Li X -Y. Effects of ginkgolides on interleukin-1, tumor necrosis factor-α and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro .  Arzneim-Forsch/Drug Res. 1998;  48 1126-30
    PubMedGoogle Scholar
  • 8 Cheng F, Siow Y L, Karmin O. Inhibition by gingkolides and bilobalide of the production of nitric oxide in macrophages (THP-1) but not in endothelial cells (HUVEC).  Biochem Biopharmacol. 2001;  61 503-10
    PubMedGoogle Scholar
  • 9 Kondratskaya E L, Lishko P V, Chatterjee S S, Krishtal O A. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel.  Neurochemistry International. 2002;  40 647-53
    CrossrefPubMedGoogle Scholar
  • 10 Ivic L, Sands T TJ, Fishkin N, Nakanishi K, Kriegstein AR & Strømgaard K. Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABAA receptors.  J Biol Chem. 2003;  278 49 279-85
    PubMedGoogle Scholar
  • 11 Suehiro M, Simpson N, van Heertum R. Radiolabeling of ginkgolide B with 18F.  J Labelled Compds Radiopharm. 2004;  47 485-91
    PubMedGoogle Scholar
  • 12 Suehiro M, Strømgaard K, Simpson N, Nakanishi K, van Heertum R. Radiolabeling of ginkgolide B with 18F and 3H.  J Labelled Compods Radiopharm. 2003;  46 (Suppl 1) S214
    PubMedGoogle Scholar
  • 13 Maruyama M, Terahara A, Itagaki Y, Nakanishi K. Ginkgolide I. Tetrahedron Lett 1967: 299-302
    Google Scholar
  • 14 Zekri O, Boudeville P, Genay P, Perly B, Braquet P, Jouenne P, Burgot J -L. Ionization constants of ginkgolide B in aqueous solution.  Anal Chem. 1996;  68 2598-604
    CrossrefPubMedGoogle Scholar
  • 15 Fourtillan J B, Brisson A M, Girault J, Ingrand J, Decourt J P, Drieu K. et al . Proprietes pharmacocietiques du bilobalide et des ginkgolides A et B chez le sujet sain après administrations intraveineuses et orales d’extrait de Ginkgo biloba (EGb 761).  Therapie. 1995;  50 137-44
    PubMedGoogle Scholar
  • 16 Dalenback J, Abrahamson H, Bjornson E, Fandriks L, Mattson A, Olbe L. et al . Human duodenogastric reflux, retroperistalsis, and MMC.  Am J Physiol. 1996;  270 G113-22
    PubMedGoogle Scholar
  • 17 Castedal M, Bjornson E, Gretarsdottir J, Fjalling H, Abrahamson H. Scintigraphic assessment of interdigestive duodenogastric reflux in humans: distinguishing between duodenal and biliary reflux material.  Scand J Gastroenterol. 2000;  35 590-8
    CrossrefPubMedGoogle Scholar
  • 18 Veldhuyzen van Zanten S JO, Goldie J, Hollingsworth J, Silletti C, Richardson H, Hunt R H. Secretion of intravenously administered antibiotics in gastric juice: implication for management of Helicobacter pylori .  Clin Pathol. 1992;  45 225-7
    PubMedGoogle Scholar
  • 19 Rathbone B J, Johnson A W, Wyatt J I, Heatley R V, Losowsky M S. Ascorbic acid: a factor concentrated in human gastric juice.  Clininal Science. 1989;  76 237-41
    PubMedGoogle Scholar
  • 20 Filep J, Herman F, & Braquet P. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.  Lipids. 1991;  26 1356-8
    PubMedGoogle Scholar
  • 21 Wallace J L, Steel G, Whittle B JR, Lagente V, Vargaftic B. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat.  Gastroenterol. 1987;  93 765-73
    PubMedGoogle Scholar

Makiko Suehiro, Ph. D.

Department of Radiology

Citigroup Biomedical Imaging Center

Weill Medical College of Cornell University

516 East 72nd Street

New York

NY 10021

USA

Phone: +1-212-746-5853

Email: mas2048@med.cornell.edu

      >